To further support this as key pathways, analysis of breast cancer patients without systemic recurrence show higher frequency of TGF-β2 and BMP7, while the disease-free survival rate of patients with detectable BMP7 is higher than those without BMP7 [54]. The gene discussed is BMP7; the disease is breast carcinoma.